Full Thickness Macular Hole
8
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Intraocular Gas Tamponade for Treatment of Large Idiopathic Macular Holes
Subjective Pain Scoring for Subtenonal Anesthesia During Vitrectomy
Full Thickness Macular Hole; Should it be Handled Subacutely?
Foveal Sparing ILM Peeling With ILM Flap Transposition
Inverted Flap Versus Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes
Inflammasomes in Cell Death in FTMH, ERM, and RRD
Protocol for RCT of Posturing in Phacovitrectomy for Full Thickness Macular Hole (FTMH)
Pilot Randomised Controlled Trial of Posturing Following Surgery for Full-thickness Macular Hole